These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 33446148)
21. Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status. Siena S; Rivera F; Taieb J; Peeters M; Prenen H; Koukakis R; Demonty G; Köhne CH Clin Colorectal Cancer; 2018 Mar; 17(1):50-57.e8. PubMed ID: 29096990 [TBL] [Abstract][Full Text] [Related]
22. Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer. Xu T; Li J; Wang Z; Zhang X; Zhou J; Lu Z; Shen L; Wang X Cancer Med; 2023 May; 12(9):10473-10484. PubMed ID: 36912150 [TBL] [Abstract][Full Text] [Related]
23. BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis. Cremolini C; Di Bartolomeo M; Amatu A; Antoniotti C; Moretto R; Berenato R; Perrone F; Tamborini E; Aprile G; Lonardi S; Sartore-Bianchi A; Fontanini G; Milione M; Lauricella C; Siena S; Falcone A; de Braud F; Loupakis F; Pietrantonio F Ann Oncol; 2015 Oct; 26(10):2092-7. PubMed ID: 26153495 [TBL] [Abstract][Full Text] [Related]
24. Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival. Ciardiello D; Famiglietti V; Napolitano S; Esposito L; Pietrantonio F; Avallone A; Maiello E; Cremolini C; Troiani T; Martinelli E; Ciardiello F; Martini G Clin Colorectal Cancer; 2022 Jun; 21(2):141-148. PubMed ID: 35101346 [TBL] [Abstract][Full Text] [Related]
25. RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients. Yao J; Zang W; Ge Y; Weygant N; Yu P; Li L; Rao G; Jiang Z; Yan R; He L; Yu Y; Jin M; Cheng G; An G Can J Gastroenterol Hepatol; 2018; 2018():4248971. PubMed ID: 29707525 [TBL] [Abstract][Full Text] [Related]
26. Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China. Xu Y; Wang G; Zheng X; Chang W; Fu J; Zhang T; Lin Q; Lv Y; Zhu Z; Tang W; Xu J Eur J Surg Oncol; 2023 Nov; 49(11):106981. PubMed ID: 37455182 [TBL] [Abstract][Full Text] [Related]
27. Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer. Horn L; Bauml J; Forde PM; Davis KL; Myall NJ; Sasane M; Dalal A; Culver K; Wozniak AJ; Baik CS; Mutebi A; Zhang P; Wakelee HA; Johnson BE Lung Cancer; 2019 Feb; 128():74-90. PubMed ID: 30642457 [TBL] [Abstract][Full Text] [Related]
28. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294 [TBL] [Abstract][Full Text] [Related]
29. The BEETS (JACCRO CC-18) trial: an observational and translational study of Inagaki C; Matoba R; Yuki S; Shiozawa M; Tsuji A; Inoue E; Muro K; Ichikawa W; Fujii M; Sunakawa Y Future Oncol; 2023 Jun; 19(17):1165-1174. PubMed ID: 37458152 [TBL] [Abstract][Full Text] [Related]
30. Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal Cancer. Yaeger R; Kotani D; Mondaca S; Parikh AR; Bando H; Van Seventer EE; Taniguchi H; Zhao H; Thant CN; de Stanchina E; Rosen N; Corcoran RB; Yoshino T; Yao Z; Ebi H Clin Cancer Res; 2019 Dec; 25(23):7089-7097. PubMed ID: 31515458 [TBL] [Abstract][Full Text] [Related]
31. Optimization of Santos C; Azuara D; Garcia-Carbonero R; Alfonso PG; Carrato A; Elez ME; Gomez A; Losa F; Montagut C; Massuti B; Navarro V; Varela M; Lopez-Doriga A; Moreno V; Valladares M; Manzano JL; Vieitez JM; Aranda E; Sanjuan X; Tabernero J; Capella G; Salazar R Mol Cancer Ther; 2017 Sep; 16(9):1999-2007. PubMed ID: 28626084 [TBL] [Abstract][Full Text] [Related]
32. A validated prognostic classifier for Loupakis F; Intini R; Cremolini C; Orlandi A; Sartore-Bianchi A; Pietrantonio F; Pella N; Spallanzani A; Dell'Aquila E; Scartozzi M; De Luca E; Rimassa L; Formica V; Leone F; Calvetti L; Aprile G; Antonuzzo L; Urbano F; Prenen H; Negri F; Di Donato S; Buonandi P; Tomasello G; Avallone A; Zustovich F; Moretto R; Antoniotti C; Salvatore L; Calegari MA; Siena S; Morano F; Ongaro E; Cascinu S; Santini D; Ziranu P; Schirripa M; Buggin F; Prete AA; Depetris I; Biason P; Lonardi S; Zagonel V; Fassan M; Di Maio M Eur J Cancer; 2019 Sep; 118():121-130. PubMed ID: 31330487 [TBL] [Abstract][Full Text] [Related]
33. Encorafenib plus cetuximab treatment in BRAF V600E-mutated metastatic colorectal cancer patients pre-treated with an anti-EGFR: An AGEO-GONO case series. Hafliger E; Boccaccino A; Lapeyre-Prost A; Perret A; Gallois C; Antista M; Pilla L; Lecomte T; Scartozzi M; Soularue E; Salvatore L; Bourgeois V; Salati M; Tougeron D; Evesque L; Vaillant JN; El-Khoury R; Lonardi S; Cremolini C; Taieb J Eur J Cancer; 2022 Jun; 168():34-40. PubMed ID: 35436675 [TBL] [Abstract][Full Text] [Related]
34. RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy. Alonso-Espinaco V; Cuatrecasas M; Alonso V; Escudero P; Marmol M; Horndler C; Ortego J; Gallego R; Codony-Servat J; Garcia-Albeniz X; Jares P; Castells A; Lozano JJ; Rosell R; Maurel J Eur J Cancer; 2014 Jul; 50(11):1973-81. PubMed ID: 24833563 [TBL] [Abstract][Full Text] [Related]
35. Characteristics of de la Fouchardière C; Cohen R; Malka D; Guimbaud R; Bourien H; Lièvre A; Cacheux W; Artru P; François E; Gilabert M; Samalin-Scalzi E; Zaanan A; Hautefeuille V; Rousseau B; Senellart H; Coriat R; Flippot R; Desseigne F; Lardy-Cleaud A; Tougeron D Oncologist; 2019 Dec; 24(12):e1331-e1340. PubMed ID: 31152084 [TBL] [Abstract][Full Text] [Related]
36. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study. Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918 [TBL] [Abstract][Full Text] [Related]